Lai Wang Insider Trades & Stock Holdings

President, Global Head of R&D · BeOne Medicines AG · Latest filing Jun 23, 2026

Lai Wang, President, Global Head of R&D at BeOne Medicines AG has 1 Form 4 trade on file since Jun 23, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($295.56K), net -$295.56K. Latest filing: disposed of 1.07K shares of $ONC on Jun 23, 2026 at $276.74.

Trades on file

1

Open-market bought

$0

Open-market sold

$295.56K

Net open-market

-$295.56K

Latest filing

Jun 23, 2026

All insider trades by Lai Wang

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 23, 2026	$ONC	Sell (Open-market sale)	1.07K	$276.74	$295.56K			+3.2%	+18.3%		President, Global Head of R&D		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Lai Wang traded

• $ONC

Frequently asked questions

Has Lai Wang been buying or selling stock?

Lai Wang has 0 open-market purchases and 1 open-market sale on file, net -$295.56K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Lai Wang's latest insider trade?

disposed of 1.07K shares of $ONC on Jun 23, 2026 at $276.74.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.